FJ Capital Management LLC raised its stake in shares of Globe Life Inc. (NYSE:GL - Free Report) by 720.5% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 39,450 shares of the company's stock after buying an additional 34,642 shares during the quarter. FJ Capital Management LLC's holdings in Globe Life were worth $5,196,000 at the end of the most recent reporting period.
A number of other large investors have also recently bought and sold shares of GL. Nuveen LLC acquired a new stake in Globe Life during the 1st quarter valued at $131,608,000. GAMMA Investing LLC grew its holdings in Globe Life by 15,553.5% during the 1st quarter. GAMMA Investing LLC now owns 781,890 shares of the company's stock valued at $102,991,000 after buying an additional 776,895 shares during the last quarter. Ameriprise Financial Inc. grew its holdings in Globe Life by 58.6% during the 4th quarter. Ameriprise Financial Inc. now owns 917,994 shares of the company's stock valued at $102,376,000 after buying an additional 339,162 shares during the last quarter. BNP Paribas Financial Markets acquired a new stake in Globe Life during the 4th quarter valued at $20,505,000. Finally, Two Sigma Advisers LP grew its holdings in Globe Life by 69.7% during the 4th quarter. Two Sigma Advisers LP now owns 393,800 shares of the company's stock valued at $43,917,000 after buying an additional 161,700 shares during the last quarter. Institutional investors and hedge funds own 81.61% of the company's stock.
Globe Life Trading Down 1.2%
Globe Life stock traded down $1.73 during midday trading on Friday, reaching $139.73. The stock had a trading volume of 343,735 shares, compared to its average volume of 515,230. Globe Life Inc. has a twelve month low of $99.04 and a twelve month high of $144.00. The stock has a market capitalization of $11.32 billion, a PE ratio of 11.17 and a beta of 0.56. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.06 and a current ratio of 0.06. The stock's 50-day simple moving average is $132.57 and its 200 day simple moving average is $126.10.
Globe Life (NYSE:GL - Get Free Report) last issued its earnings results on Wednesday, July 23rd. The company reported $3.27 earnings per share for the quarter, beating analysts' consensus estimates of $3.25 by $0.02. Globe Life had a return on equity of 21.24% and a net margin of 18.11%.The firm had revenue of $1.48 billion for the quarter, compared to analysts' expectations of $1.50 billion. During the same quarter last year, the firm earned $2.97 earnings per share. The firm's revenue for the quarter was up 2.9% compared to the same quarter last year. Globe Life has set its FY 2025 guidance at 14.250-14.650 EPS. Analysts expect that Globe Life Inc. will post 13.87 EPS for the current year.
Globe Life Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, October 3rd will be issued a $0.27 dividend. The ex-dividend date is Friday, October 3rd. This represents a $1.08 dividend on an annualized basis and a yield of 0.8%. Globe Life's dividend payout ratio (DPR) is presently 8.63%.
Insider Transactions at Globe Life
In related news, CEO James Matthew Darden sold 33,270 shares of Globe Life stock in a transaction on Friday, July 25th. The stock was sold at an average price of $135.59, for a total value of $4,511,079.30. Following the transaction, the chief executive officer owned 49,842 shares in the company, valued at approximately $6,758,076.78. This trade represents a 40.03% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Michael Clay Majors sold 10,000 shares of Globe Life stock in a transaction on Friday, August 1st. The shares were sold at an average price of $137.41, for a total value of $1,374,100.00. Following the completion of the transaction, the executive vice president owned 47,066 shares in the company, valued at $6,467,339.06. The trade was a 17.52% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 84,722 shares of company stock worth $11,733,793 over the last ninety days. 1.51% of the stock is owned by insiders.
Analyst Ratings Changes
A number of brokerages have commented on GL. Cfra Research upgraded Globe Life to a "moderate buy" rating in a report on Friday, July 25th. Wall Street Zen upgraded Globe Life from a "hold" rating to a "buy" rating in a report on Friday, May 16th. BMO Capital Markets restated a "market perform" rating and set a $149.00 price objective (up previously from $114.00) on shares of Globe Life in a report on Wednesday, July 30th. JPMorgan Chase & Co. raised their price objective on Globe Life from $145.00 to $160.00 and gave the stock an "overweight" rating in a report on Tuesday, July 8th. Finally, Truist Financial began coverage on Globe Life in a report on Tuesday, July 15th. They set a "buy" rating and a $150.00 price objective on the stock. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have given a Hold rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $152.45.
Get Our Latest Research Report on Globe Life
About Globe Life
(
Free Report)
Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.
Read More

Before you consider Globe Life, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Globe Life wasn't on the list.
While Globe Life currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.